Document Library

Ministry of Health only provides coverage for a maximum of three doses for an eligible patient.
Determining and providing proof of patient eligibility for IV Remdesivir therapy is the Prescriber’s responsibility, namely:
The individual does not require hospitalization;
AND the individual cannot take Paxlovid (nirmatrelvir and ritonavir), e.g., due to a drug interaction or contraindication;
AND the individual has a positive COVID-19 test result (molecular or rapid antigen) and has had symptoms for fewerthan 8 days at the time treatment is initiated (dose 1).